Clinical Trial Update: PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes [Phase 4]

View source ↗

Summary

The Phase 4 PRoFESS trial comparing aspirin plus extended-release dipyridamole versus clopidogrel for secondary stroke prevention has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Aggrenox (Aspirin + extended-release dipyridamole) (Aspirin and dipyridamole combination (extended-release))
• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• Dipyridamole (extended-release) (Dipyridamole extended-release)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Stroke | Phase 4 | Status: COMPLETED | Results posted: 2009-09-02